메인로고 메인로고

언어변경 언어변경

About Us

History

History

The Company growing
with customers

2023

10 Patent Registration (No. 10-2598899)
04 Designated as a Global Small but Strong Enterprise 1000+ (Ministry of SMEs and Startups)
01 ANVISA (Brazilian GMP)

2022

Selected as a Military Service Alternative Workplace
(The Korea Military Manpower Administration)
 12
MELINE® No.3 Lidocaine Product registered for national sales in Korea
(The Korea Ministry of Food and Drug Safety)
 07
Designated as a 2022 Promising Export Small & Medium Enterprise
(Ministry of SMEs and Startups)
 01

2021

04 ISO:13485(TÜV SÜD)
02 Completion of Clinical Study forMELINE® No.3 Lidocaine

2020

Selected for the Startup Growth Technology Development Project
(The Korea Ministry of SMEs and Startups)
Selected for the Multi-Ministry Full-Cycle Medical Device Business
(KMDF)
 06
Clinical Trial Approval for Meline® No.3 Lidocaine Medical Device
 01

2019

07 Selected for the Innovative Task of Startup Growth Technology Development Project
(The Korea Ministry of SMEs and Startups)
06 Selected for the Startup Leap Package Support Project
(The Korea Ministry of SMEs and Startups)

2018

Selected for the Startup Growth Technology Development Project
(The Korea Ministry of SMEs and Startups)
 12
Designated as a Global IP Star Company
(The Korean Intellectual Property Office)
 04

2017

12 Capital Increase of 400 Million KRW (Total Capital 2.9 Billion KRW)
10 Cosmetic Distributor License Approved (The Korea Ministry of Food and Drug Safety)
09 Capital Increase of 1 Billion KRW (Total Capital 2.5 Billion KRW)

2016

GMP Certification (The Korea Ministry of Food and Drug Safety)
 11
Venture Certification (The Korea Technology Finance Corporation)
 09
Completion of Preclinical trial forMELINE® No.3 Lidocaine
(The Korea Testing & Research Institute, KTR)
 08
Factory Registration
 03
Change of CEO, Company Name, and Registered Executives
 02
Capital Increase of 500 Million KRW,
Amendment of Articles of Incorporation (Total Capital 1.5 Billion KRW)
 01

2015

09 Capital Increase of 800 Million KRW (Total Capital 1 Billion KRW)
Establishment of Corporate-Affiliated Research Institute
08 Medical Device Manufacturing and Export License Approved
(The Korea Ministry of Food and Drug Safety)
Amendment of Articles of Incorporation, Change of Auditor, Change of Registered Executives
07 Move into Hoseo University Industry-Academic Cooperation Building
Establishment of Bio Standard Co., Ltd. (Initial Capital 200 Million KRW)